According to Enliven Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.53. In 2021 the company made an earnings per share (EPS) of -$0.60 a decrease over its 2020 EPS that were of -$0.46.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.53 | |
2021 | -$0.60 | 30.44% |
2020 | -$0.46 |